OT: BW in ANCOVA [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2019-06-18 15:39 (1764 d 01:09 ago) – Posting: # 20335
Views: 4,276

Hi ElMaestro,

❝ I believe they meant to do an ANCOVA with total dose as covariate.


So do I.

At the 2nd GBHI conference (Rockville 2016) body weight as a covariate was a hot topic. Body weight changes quite often in studies of anti-cancer drugs. The FDA was happy with that. No way for the EMA – as usual.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
22,984 posts in 4,822 threads, 1,651 registered users;
50 visitors (0 registered, 50 guests [including 4 identified bots]).
Forum time: 16:49 CEST (Europe/Vienna)

You can’t fix by analysis
what you bungled by design.    Richard J. Light, Judith D. Singer, John B. Willett

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5